A Review on Pilocarpine Ousert : A Controlled Ocular Drug Delivery Approach for Glaucoma
Fuente:
Zenodo
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Recurso digital |
| Veröffentlicht: |
Zenodo
2025
|
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866901600278151168 |
|---|---|
| author | Aghav Sonali R, Prof.Dr.Shete Abhijit, Dr.Salve Megha T |
| author_facet | Aghav Sonali R, Prof.Dr.Shete Abhijit, Dr.Salve Megha T |
| contents | <p>Pilocarpine Ocusert is a controlled-release ocular implant used to treat glaucoma by directly delivering the muscarinic<br>agonist pilocarpine to the eye. By delivering pilocarpine in a continuous release, this novel delivery method lowers<br>intraocular pressure (IOP) and enhances therapeutic results. The benefits of the Ocusert include increased efficacy,<br>decreased systemic adverse effects, and better patient compliance. The Ocusert slows the growth of glaucoma and<br>preserves eyesight by ensuring a steady delivery of medication. The need for patient education and encouragement,<br>retention issues (some patients were unaware when the device was lost), sporadic side effects like a cutting sensation<br>(the Ocusert occasionally doubles over), eye movement, temporary blurring of vision, and miosis, and high cost were<br>some of the drawbacks. All things considered, the Ocusert pilocarpine system has several clear benefits over pilocarpine<br>eyedrops and is a very popular therapeutic approach for some glaucoma cases. </p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17658840 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | A Review on Pilocarpine Ousert : A Controlled Ocular Drug Delivery Approach for Glaucoma Aghav Sonali R, Prof.Dr.Shete Abhijit, Dr.Salve Megha T <p>Pilocarpine Ocusert is a controlled-release ocular implant used to treat glaucoma by directly delivering the muscarinic<br>agonist pilocarpine to the eye. By delivering pilocarpine in a continuous release, this novel delivery method lowers<br>intraocular pressure (IOP) and enhances therapeutic results. The benefits of the Ocusert include increased efficacy,<br>decreased systemic adverse effects, and better patient compliance. The Ocusert slows the growth of glaucoma and<br>preserves eyesight by ensuring a steady delivery of medication. The need for patient education and encouragement,<br>retention issues (some patients were unaware when the device was lost), sporadic side effects like a cutting sensation<br>(the Ocusert occasionally doubles over), eye movement, temporary blurring of vision, and miosis, and high cost were<br>some of the drawbacks. All things considered, the Ocusert pilocarpine system has several clear benefits over pilocarpine<br>eyedrops and is a very popular therapeutic approach for some glaucoma cases. </p> |
| title | A Review on Pilocarpine Ousert : A Controlled Ocular Drug Delivery Approach for Glaucoma |
| url | https://doi.org/10.5281/zenodo.17658840 |